NDMA senna task group requests meeting with FDA on OTC laxative ingredient's safety..
This article was originally published in The Tan Sheet
Executive Summary
NDMA SENNA TASK GROUP REQUESTS MEETING WITH FDA to discuss the safety of the OTC laxative ingredient. In a Nov. 5 letter to the agency, NDMA Senior VP and Director of Science & Technology William Soller, PhD, suggested that members of the task group and Center for Drug Evaluation & Research officials meet to address FDA's "concerns with the safety of senna."